Results for tag: "Buparvaquone"

Buparvaquone is an animal pharmaceutical drug used to treat and prevent the protozoal infection, theileriosis, in cattle, sheep, and goats. It is a synthetic, broad-spectrum antiprotozoal agent that works by inhibiting the growth of the protozoan parasites. Buparvaquone is administered orally, either as a single dose or as a course of treatment. It is available in both injectable and oral formulations. Buparvaquone is widely used in the animal pharmaceuticals market, as it is effective in treating and preventing theileriosis in livestock. It is also used to treat other protozoal infections, such as babesiosis and anaplasmosis. Buparvaquone is generally well-tolerated and has few side effects. Some companies in the buparvaquone market include Merial, Boehringer Ingelheim, Elanco, and Zoetis. Show Less Read more